《新股》华昊中天医药(02563.HK)公开发售获21.5倍认购 一手中签率4.45%

阿斯达克财经
31 Oct 2024

华昊中天医药-B(02563.HK)公布招股结果,公开发售接获21.45倍认购,一手(200股)中签率4.45%,认购30手始获稳派一手;国际发售录得0.994倍认购。最终发售价16元,下限定价,集资净额1.96亿元。股份预期周四(31日)挂牌。
生物医药公司华昊中天医药是次全球发售1,458.8万股,公开发售占10%;招股价介乎16元至22元。联席保荐人建银国际及中信建投国际。(de/d)(港股报价延迟最少十五分钟。)

AASTOCKS新闻

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10